Last updated: 2026-09-06 10:19:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
10x Genomics, Inc. (TXG) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $62.59, with a market capitalization of $8.16B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $11.16 to $66.94. This page covers its latest market performance, valuation, price trends and company information.
$8.16B | |
$62.54 | |
$208.99 | |
$6.78 | |
$63.22 | |
1.28M | |
3.14M | |
-- | |
$66.94 | |
$11.16 | |
-- | |
-- |
10x Genomics, Inc. (TXG) last closed at $63.22 as of 2026-09-04 23:31:00, unchanged from the previous close of $63.22.
During the latest regular trading session, TXG traded between $6.78 and $208.99, with a volume of 1.28M shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, 10x Genomics, Inc. (TXG) moved from $64.85 to $62.59, representing a decline of 3.48% ($2.26).
The stock traded between $58.70 and $65.74 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 2.08 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 92.2%
TXG is currently trading at $62.59, placing it 92.2% of the way from its 52-week low of $11.16 to its 52-week high of $66.94. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 1178 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of 10x Genomics, Inc. (TXG) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.